Humira, Enbrel Face Pricing Pressures From Copay Accumulator Programs

Payer efforts to undercut copay assistance are getting manufacturers’ attention. PhRMA launches ad campaign warning patients that 'middlemen' are 'trying to keep you from reaching your deductible.'

AbbVie Inc. expects to increase its cost sharing assistance for Humira (adalimumab) patients going forward as a result of the expanded use of commercial insurance policies designed to undercut the value of copay coupons, according to Chairman and CEO Richard Gonzalez.

Copay accumulator programs, which are becoming more widely used by payers, block the financial assistance provided by manufacturers from being...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access